or Try an Advanced Search...

    Technical Analysis for ADIL - Adial Pharmaceuticals, Inc

    Grade Last Price % Change Price Change
    D 1.01 1.00% 0.01
    ADIL closed up 1.0 percent on Friday, November 1, 2024, on 33 percent of normal volume. It ran into resistance at its 50 day moving average.
    Earnings due: Nov 12
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ADIL trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    50 DMA Resistance Bearish 0.00%
    20 DMA Resistance Bearish 1.00%
    50 DMA Resistance Bearish 1.00%
    MACD Bearish Signal Line Cross Bearish 1.00%
    Fell Below 20 DMA Bearish 1.46%
    Fell Below 50 DMA Bearish 1.46%
    Calm After Storm Range Contraction 1.46%
    NR7 Range Contraction 1.46%
    Down 3 Days in a Row Weakness 1.46%
    Older End-of-Day Signals for ADIL ...

       Recent Intraday Alerts

    Alert Time
    50 DMA Resistance about 22 hours ago
    20 DMA Resistance about 22 hours ago
    Rose Above 20 DMA about 22 hours ago
    Rose Above 50 DMA about 22 hours ago
    Up 1% about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ADIL Chart by TradingView
    Basic chart:

    Profile

    Adial Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of a therapeutic agent for the treatment of alcohol use disorder (AUD). Its lead drug product is AD04. AD04 is a selective serotonin-3 antagonist. AD04 can also be used for the treatment of other addictive disorders, such as obesity, smoking, and drug addiction. The Company has completed a Phase-II clinical trials of AD04.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Alcohol Medication Mental Health Obesity Psychiatry Smoking Drug Products Addiction

    Is ADIL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 23 Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference
    Oct 17 Adial Pharmaceuticals Receives Notice of Allowance for U.S. Patent Covering Expanded Genotype Combinations Identified Using the Company’s Genetic Diagnostic for Addiction Treatment
    Oct 17 EXCLUSIVE: Adial Pharmaceuticals Secures Additional US Patent Expanding Intellectual Property Protection Around Its Alcohol Use Disorder Candidate
    Oct 15 Adial Pharmaceuticals Commends the National Institute on Alcohol Abuse and Alcoholism's New Definition of Recovery
    Sep 19 Adial Pharmaceuticals Announces Database Lock in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
    Sep 4 Adial Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
    Aug 15 Adial Pharmaceuticals reports Q2 results
    Aug 14 Adial Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
    Aug 13 Adial Pharmaceuticals Signs Agreement with Boudicca Dx to Advance Regulatory Strategy for Companion Diagnostic Genetic Test for AD04
    Aug 13 EXCLUSIVE: Adial Pharmaceuticals Advances Regulatory Strategy For Companion Diagnostic Genetic Test For Its Lead Program For Alcohol Use Disorder
    See more ADIL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.1699
    52 Week Low 0.765
    Average Volume 115,573
    200-Day Moving Average 1.29
    50-Day Moving Average 1.02
    20-Day Moving Average 1.01
    10-Day Moving Average 1.06
    Average True Range 0.06
    RSI (14) 48.98
    ADX 21.45
    +DI 16.60
    -DI 16.23
    Chandelier Exit (Long, 3 ATRs) 1.00
    Chandelier Exit (Short, 3 ATRs) 1.12
    Upper Bollinger Bands 1.14
    Lower Bollinger Band 0.89
    Percent B (%b) 0.49
    BandWidth 24.14
    MACD Line 0.00
    MACD Signal Line 0.01
    MACD Histogram -0.0034
    Fundamentals Value
    Market Cap 1.68 Million
    Num Shares 1.66 Million
    EPS -8.98
    Price-to-Earnings (P/E) Ratio -0.11
    Price-to-Sales 0.00
    Price-to-Book 0.82
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.07
    Resistance 3 (R3) 1.07 1.05 1.06
    Resistance 2 (R2) 1.05 1.03 1.05 1.06
    Resistance 1 (R1) 1.03 1.02 1.04 1.03 1.06
    Pivot Point 1.00 1.00 1.01 1.00 1.00
    Support 1 (S1) 0.98 0.99 0.99 0.99 0.96
    Support 2 (S2) 0.96 0.98 0.96 0.96
    Support 3 (S3) 0.94 0.96 0.96
    Support 4 (S4) 0.95